日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Providing LGBTQ+ Adolescents With Nurturance, Trustworthiness, and Safety: A Community-Informed, Theory-Grounded, Evidence-Based Intervention for High School Staff

为 LGBTQ+ 青少年提供关爱、信任和安全:一项以社区为导向、以理论为基础、以实证为依据的高中教职工干预措施

Coulter, Robert W S; Cason, Shannon N; Dixon, Fatimah J; Wiley, Angela; Rose, Madelyn; Baral, Karuna; Mathias, Aaryn S; Lin, Clarisse A; Mahal, Isabella Kaur; Ross, Mary C; Sawicki, Kennedy N; Farhi, Sam W; Dodda, Meghana; Miller, Elizabeth

Behavioral and transcriptional effects of age in HbSS-BERK humanized SCD mice

HbSS-BERK人源化SCD小鼠的行为和转录水平随年龄变化的影响

Goldsborough, Kennedy N; Taylor, Michael W; McKiver, Bryan D; Muchhala, Karan H; Sonenklar, Molly E; Adu-Gyamfi, Atuahene; Herz, Sara M; Jessup, Dawn K; Lloyd, Joyce A; Akbarali, Hamid I; Damaj, M Imad; Gupta, Kalpna; Smith, Wally R; Lichtman, Aron H

Repeated infection by cytomegalovirus induces neuroinflammation and compromises BBB integrity

巨细胞病毒反复感染会诱发神经炎症并损害血脑屏障完整性。

Carr, Margaret F; Frank, Loren M; Rocco, Grace; Lin, Henry; Said, Kailey A; Boudreau, Ryan L; McLendon, Jared M; Barahona, Natasha B; Garfinkel, Lucas P; Wang, Hanyun; Marcus, Miayla; Subramanian, Advaith; Willis, Kennedy N; Harrison, Mark A; Morris, Sara; Zwezdaryk, Kevin; Engler‐Chiurazzi, Elizabeth

Hypophosphatemia attenuates improvements in vitality after intravenous iron treatment in patients with inflammatory bowel disease

低磷血症会减弱炎症性肠病患者静脉注射铁剂治疗后活力的改善。

Bjorner, J B; Kennedy, N; Lindgren, S; Pollock, R F

Healthcare use attributable to COVID-19: a propensity-matched national electronic health records cohort study of 249,390 people in Wales, UK

英国威尔士249,390人参与的倾向性匹配全国电子健康记录队列研究:与COVID-19相关的医疗保健使用情况

Kennedy, J; Parker, M; Seaborne, M; Mhereeg, M; Walker, A; Walker, V; Denaxas, S; Kennedy, N; Katikireddi, S V; Brophy, S

OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab

OP21 研究表明,接受英夫利昔单抗、乌司奴单抗或托法替尼治疗的炎症性肠病患者,其新冠疫苗诱导的抗体反应受损;而接受硫嘌呤类药物或维多珠单抗治疗的患者,其抗体反应则不受影响。

Verburgt, Charlotte M; Dunn, Katherine A; Van Limbergen, Johan E; Alexander, J; Kennedy, N; Ibraheim, H; Anandabaskaran, S; Saifuddin, A; Castro Seoane, R; Liu, Z; Nice, R; Bewshea, C; D’Mello, A; Constable, L; Jones, G R; Balarajah, S; Fiorentino, F; Sebastian, S; Irving, P M; Hicks, L; Williams, H; Kent, A; Linger, R; King, R; Parkes, M; Kok, K; Patel, K; Altmann, D; Boyton, R; Goodhand, J; Hart, A; Lees, C; Ahmad, T; Powell, N

P641 Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey

P641 抗SARS-CoV-2疫苗在炎症性肠病患者中的实施及短期不良事件:一项国际网络调查

Bishu, Shrinivas; Ungaro, R; Siegel, C A; Cree, B A C; Selmaj, K W; Ahmad, H A; Pai, A; Ather, S; Henry, A; Charles, L; Petersen, A; Cheng, C Y; Afsari, S; Sheffield, J; Vaile, J; Colombel, J F; Mayorga Ayala, L F; Herrera-deGuise, C; Esperalba, J; Martinez-Gomez, X; Céspedes Martinez, E; Robles Alonso, V; Jimenez, A; Perez Martinez, Z; Oller, E; Ibarz, A; Fernandez-Naval, C; Martinez-Gallo, M; Lopez Messeguer, M; Casellas, F; Borruel, N; Lelong, M; Nancey, S; Bouguen, G; Allez, M; Serrero, M; Chupin, A; Caillo, L; Viennot, S; Blanc, P; Reimund, J M; Laharie, D; Olivier, R; Laurent, P B; Dib, N; De Maissin, A; Montuclard, C; Trang-Poisson, C; Gaillot, G; Bressollette-Bodin, C; Berthome, M; Burel, M; Vavasseur, F; Bourreille, A; Le Berre, C; Reinisch, W; Colombel, J F; D’Haens, G R; Rimola, J; DeHaas-Amatsaleh, A; McKevitt, M; Ren, X; Serone, A; Schwartz, D A; Gecse, K B; Peyrin-Biroulet, L; Colombel, J F; Louis, E; Ferrante, M; Motoya, S; Panaccione, R; Torres, J; Ungaro, R C; Kligys, K; Kalabic, J; Zambrano, J; Zhang, Y; D’Haens, G R; de Voogd, F; Bots, S; Van Wassenaer, E; De Jong, M; Pruijt, M; Löwenberg, M; D’Haens, G; Gecse, K; Otten, A T; Bourgonje, A R; Horinga, P P; van der Meulen, H H; van Leer-Buter, C C; Dijkstra, G; Visschedijk, M C; Orfanoudaki, E; Zacharopoulou, E; Kitsou, V; Karmiris, K; Theodoropoulou, A; Mantzaris, G J; Tzouvala, M; Michopoulos, S; Zampeli, E; Michalopoulos, G; Karatzas, P; Viazis, N; Liatsos, C; Bamias, G; Koutroubakis, I E; Martin Arranz, M D; García Ramírez, L; Montero Vega, D; Martín-Arraz, E; Sánchez Azofra, M; Poza Cordon, J; Rueda Garcia, J L; Noci Belda, J; Verges Martínez-Meco, T; Blanco San Miguel, P; Suarez Ferrer, C; Babayeva-Sadigova, G; Makhmudov, U; Quliyev, F; Asadova, G; Mirzazade, O; Samadova, T; Hasanova, A; Costantino, A; Caprioli, F; Vecchi, M; Stocco, D; Aloi, M; Armuzzi, A; Ficari, F; Manguso, F; Mocci, G; Orlando, A; Pironi, L; Radice, S; Rizzello, F; Tongiorgi, A; Leone, S; Bossa, F; Saifuddin, A; Kent, A; Mehta, S; Hicks, L; Gonzalez, H; Segal, J; Brooks, M; Subramanian, S; Bhala, N; Conley, T; Patel, K; Lamb, C; Walker, G; Kennedy, N; Sebastian, S; Geldof, J; Sabino, J; Ferrante, M; Lambert, J; Lapeere, H; Hillary, T; Van Laethem, A; De Vlam, K; Verschueren, P; Lobaton, T; Vermeire, S; Bossuyt, P; Bresso, F; Dubinsky, M; Ha, C; Siegel, C; Zambrano, J; Kligys, K; Kalabic, J; Zhang, Y; Panaccione, R; Ramos Lopez, L; Hernández, A; Carrillo-Palau, M; Hernández-Camba, A; Alonso-Abreu, I; Reygosa, C; Vela, M; Rodríguez, G E; González-Mendez, Y; Tardillo, C; Arranz, L; Benítez-Zafra, F; Hernández-Guerra, M; Taxonera Samso, C; Olivares, D; Blanco, I; Velasco, E; Molina, S; López, G; López-García, O N; Alba, C; Rey, E; López Marte, P; Ramos-Tollinchi, L; Rodriguez-Martinó, E; Medina-Prieto, R; Ojeda, S; Santana-Bagur, J; Pantoja, P; Sariol, C A; Torres, E A; Macedo Silva, V; Lima Capela, T; Freitas, M; Cúrdia Gonçalves, T; Boal Carvalho, P; Dias de Castro, F; Moreira, M J; Cotter, J; Revés, J; Abreu, B; Chaparro, M; Gisbert, J P; Mariangela, A; Fiorino, G; Barberio, B; Zingone, F; Pisani, A; Cassar, D; Michalopoulos, G; Mantzaris, G; Mountaki, K; Koutroubakis, I; Karmiris, K; Katsanos, K; Ďuricova, D; Burisch, J; Madsen, G R; Maaser, C; Naila, A; Orfanoudaki, E; Milivojevic, V; Buisson, A; Avedano, L; Leone, S; Torres, J; Ellul, P

OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients

OP22 抗体衰减、T细胞免疫和SARS-CoV-2疫苗接种后英夫利昔单抗和维多珠单抗治疗患者的突破性感染

Jeong, Geum Hee; Huh, Sun; Lin, S; Kennedy, N A; Saifuddin, A; Muñoz Sandoval, D; Reynolds, C J; Seoane, R C; Kottoor, S H; Pieper, F P; Lin, K M; Butler, D K; Chanchlani, N; Nice, R; Chee, D; Bewshea, C; Janjua, M; McDonald, T J; Sebastian, S; Alexander, J L; Constable, L; Lee, J C; Murray, C D; Hart, A L; Irving, P M; Jones, G R; Kok, K B; Lamb, C A; Lees, C W; Altmann, D M; Boyton, R J; Goodhand, J R; Powell, N; Ahmad, T

Anaesthesia for bariatric surgery

减肥手术麻醉

Reeve, K; Kennedy, N

OP03 Anti-SARS-CoV2 antibody responses are attenuated in patients with Inflammatory Bowel Disease treated with infliximab

OP03 抗SARS-CoV-2抗体反应在接受英夫利昔单抗治疗的炎症性肠病患者中减弱

Delvaux, M; Kennedy, N A; Goodhand, J; Bewshea, C; Nice, R; Chee, D; Lin, S; Chanchlani, N; Butterworth, J; Cooney, R; Croft, N; Hart, A; Irving, P; Kok, K; Lamb, C; Limdi, J; MacDonald, J; McGovern, D; Mehta, S; Murray, C; Patel, K; Pollok, R; Raine, T; Russell, R; Selinger, C; Smith, P; Bowden, J; McDonald, T; Lees, C; Sebastian, S; Powell, N; Ahmad, T